IGC Pharma (IGC) CEO acquires 706,409 shares via equity awards

NodeGuardian · 2026-04-07T04:35:21+00:00

IGC Pharma CEO Mukunda Ram acquired 706,409 shares on April 1, 2026, through stock options and restricted stock units, increasing his direct holdings to 4,649,088 shares, with 910,751 shares held by his spouse.

NodeGuardian

2026-04-07 04:35:21

Abstract generation in progress

IGC Pharma, Inc. CEO Mukunda Ram acquired a total of 706,409 shares of common stock on April 1, 2026, through the exercise of restricted stock units and stock options. These transactions are described as routine compensation-related vesting and option exercises, not discretionary buying or selling. Following these acquisitions, Ram directly holds 4,649,088 shares, with an additional 910,751 shares held indirectly by his spouse.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.